T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Okta
OKTA
$25.6B
| $170M | 0.02% |
2,409,193
-1,387,382
| -37% | -$82.6M |
|
527
Host Hotels & Resorts
HST
$15.6B
| $169M | 0.02% |
8,028,587
+160,635
| +2% | +$3.4M |
|
528
Veeva Systems
VEEV
$39.2B
| $169M | 0.02% |
1,551,418
-1,700,851
| -52% | -$154M |
|
529
Hewlett Packard
HPE
$77.8B
| $168M | 0.02% |
10,284,673
-1,051,760
| -9% | -$16.8M |
|
530
Performance Food Group
PFGC
$16.9B
| $167M | 0.02% |
5,027,244
+891,870
| +22% | +$31.4M |
|
|
NUVA
531
DELISTED
NuVasive, Inc.
NUVA
| $166M | 0.02% |
2,343,513
+138,074
| +6% | +$8.79M |
|
532
Columbia Banking Systems
COLB
$9.12B
| $166M | 0.02% |
4,290,487
-33,176
| -0.8% | -$1.38M |
|
533
TherapeuticsMD
TXMD
$24.1M
| $166M | 0.02% |
506,389
+38,303
| +8% | +$11.7M |
|
534
Ironwood Pharmaceuticals
IRWD
$714M
| $165M | 0.02% |
10,655,238
-2,680,060
| -20% | -$42.4M |
|
535
Norfolk Southern
NSC
$75.3B
| $164M | 0.02% |
909,235
+420,019
| +86% | +$71.8M |
|
536
Gentherm
THRM
$1.27B
| $163M | 0.02% |
3,592,636
-357,509
| -9% | -$16.2M |
|
537
Hubbell
HUBB
$27.1B
| $161M | 0.02% |
1,208,404
-20,305
| -2% | -$2.49M |
|
538
Kemper
KMPR
$1.56B
| $161M | 0.02% |
2,004,068
+18,136
| +0.9% | +$1.42M |
|
|
GTT
539
DELISTED
GTT Communications, Inc.
GTT
| $161M | 0.02% |
3,714,697
+1,352,444
| +57% | +$57.8M |
|
540
Cameco
CCJ
$43.1B
| $161M | 0.02% |
14,130,636
-146,465
| -1% | -$1.54M |
|
|
MYOK
541
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $161M | 0.02% |
2,468,408
+102,500
| +4% | +$6.03M |
|
|
ATRI
542
DELISTED
Atrion Corp
ATRI
| $159M | 0.02% |
229,281
+692
| +0.3% | +$445K |
|
543
Wingstop
WING
$3.05B
| $159M | 0.02% |
2,327,774
-648,580
| -22% | -$39M |
|
544
Selective Insurance
SIGI
$5.59B
| $158M | 0.02% |
2,491,484
+38,935
| +2% | +$2.39M |
|
545
Bath & Body Works
BBWI
$3.65B
| $158M | 0.02% |
6,442,247
-629,724
| -9% | -$15.7M |
|
546
Papa John's
PZZA
$793M
| $158M | 0.02% |
3,074,696
+2,952,211
| +2,410% | +$137M |
|
|
INVX
547
Innovex International
INVX
$2.13B
| $154M | 0.02% |
2,956,199
+56,282
| +2% | +$2.94M |
|
548
Murphy Oil
MUR
$5.06B
| $154M | 0.02% |
4,628,194
-1,589,553
| -26% | -$50.5M |
|
549
Ally Financial
ALLY
$13.5B
| $154M | 0.02% |
5,821,382
-77,739
| -1% | -$2.11M |
|
550
First Industrial Realty Trust
FR
$8.4B
| $153M | 0.02% |
4,867,965
+619,818
| +15% | +$20.1M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.